THE TIME COURSE OF THE IMMUNE-RESPONSE TO EXPERIMENTAL CORONAVIRUS INFECTION OF MAN

被引:418
作者
CALLOW, KA
PARRY, HF
SERGEANT, M
TYRRELL, DAJ
机构
[1] HARVARD HOSP,MRC,COMMON COLD UNIT,SALISBURY SP2 8BW,WILTS,ENGLAND
[2] SALISBURY INFIRM,DEPT PATHOL,SALISBURY,WILTS,ENGLAND
关键词
D O I
10.1017/S0950268800048019
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
After preliminary trials, the detailed changes in the concentration of specific circulating and local antibodies were followed in 15 volunteers inoculated with coronavirus 229E. Ten of them, who had significantly lower concentrations of pre-existing antibody than the rest, became infected and eight of these developed colds. A limited investigation of circulating lymphocyte populations showed some lymphocytopenia in infected volunteers. In this group, antibody concentrations started to increase 1 week after inoculation and reached a maximum about 1 week later. Thereafter antibody titres slowly declined. Although concentrations were still slightly raised 1 year later, this did not always prevent reinfection when volunteers were then challenged with the homologous virus. However, the period of virus shedding was shorter than before and none developed a cold. All of the uninfected group were infected on re-challenge although they also appeared to show some resistance to disease and in the extent of infection. These results are discussed with reference to natural infections with coronavirus and with other infections, such as rhinovirus infections. © 1990, Cambridge University Press. All rights reserved.
引用
收藏
页码:435 / 446
页数:12
相关论文
共 33 条
[1]  
ALFORD RH, 1967, J IMMUNOL, V98, P4724
[2]   POTENTIAL OF INFLUENZA VACCINE AND AMANTADINE TO PREVENT INFLUENZA-A ILLNESS IN CANADIAN FORCES PERSONNEL 1980-1983 [J].
AOKI, FY ;
SITAR, DS ;
MILLEY, EV ;
HUGHES, HE ;
SEKLA, L ;
SHEPPARD, T ;
STIVER, HG ;
HAMMOND, GW ;
VERMEERSCH, C ;
COOPER, T ;
LAMONTAGE, M ;
CALLOW, K .
MILITARY MEDICINE, 1986, 151 (09) :459-465
[3]   EVALUATION OF AN ENZYME-LINKED IMMUNOSORBENT-ASSAY THAT MEASURES RHINOVIRUS-SPECIFIC ANTIBODIES IN HUMAN-SERA AND NASAL SECRETIONS [J].
BARCLAY, WS ;
CALLOW, KA ;
SERGEANT, M ;
ALNAKIB, W .
JOURNAL OF MEDICAL VIROLOGY, 1988, 25 (04) :475-482
[4]  
BARCLAY WS, 1990, EPIDEMIOL INFECT, V103, P659
[5]  
BEARE AS, 1977, CHEMOPROPHYLAXIS VIR, V2, P27
[6]   SOME FURTHER-STUDIES ON THE PREDICTION OF EXPERIMENTAL COLDS IN VOLUNTEERS BY PSYCHOLOGICAL-FACTORS [J].
BROADBENT, DE ;
BROADBENT, MHP ;
PHILLPOTTS, RJ ;
WALLACE, J .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1984, 28 (06) :511-523
[7]  
BUSCHO RF, 1972, J IMMUNOL, V108, P169
[8]  
BUTLER WT, 1970, J IMMUNOL, V105, P584
[10]   ROLE OF NASAL SECRETION AND SERUM ANTIBODY IN RHINOVIRUS COMMON COLD [J].
CATE, TR ;
ROSSEN, RD ;
DOUGLAS, RG ;
BUTLER, WT ;
COUCH, RB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1966, 84 (02) :352-+